Honyaku Center (2483) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
14 Oct, 2026Executive summary
H1 FY3/24 revenue rose 3.6% YoY to ¥5,429m, led by interpreter services and translation demand in patents and industrial localization.
Operating profit fell 9.8% to ¥350m, ordinary profit fell 6.7% to ¥364m, and net income fell 8.6% to ¥236m as SG&A increased.
Financial highlights
Revenue increased ¥191m YoY; gross profit rose 3.2% to ¥2,555m, while SG&A grew 5.6% to ¥2,204m.
Cost of sales rose 4.0% to ¥2,874m; reported gross margin was 47.0%, down 0.2 percentage points YoY.
Outlook and guidance
FY3/24 guidance: revenue ¥11,550m (+5.5% YoY), operating profit ¥1,000m (+7.6%), ordinary profit ¥1,020m (+6.1%), and net income ¥700m (+1.9%).
FY3/24 gross margin is forecast at 47.3%, up 0.9 percentage points; SG&A is forecast to increase 7.2% to ¥4,460m.
FY3/25 mid-term targets: revenue ¥12.1bn, operating profit ¥1.1bn, net income ¥750m, operating margin 9.0%, and ROE 12.0%.
Latest events from Honyaku Center
- Translation weakness drove a 58% H1 operating-profit decline and lower full-year guidance.2483
Q2 2027 - FY25 guidance targets 7% sales growth and 16.3% operating-profit growth.2483
Q4 2024 - Translation weakness drove an 8.0% sales decline as Interpretation reached a first-quarter record.2483
Q1 2027 - Net sales rose 5.3% year-over-year, but net income declined 4.0% amid macroeconomic uncertainty.2483
Q1 2025 - Interpreting growth lifted 1H sales; FY guidance targets stronger profit and a record ¥75 dividend.2483
Q2 2025 - Net income rose 4.6% year-over-year to ¥418 million, driven by a gain on sale of subsidiary shares.2483
Q3 2025 - Record Translation and Interpretation sales were outweighed by convention weakness and cost pressure.2483
Q4 2025 - H1 sales fell 2.2%, while net income rose and Interpretation sales reached a record.2483
Q2 2026 - FY2026 profit fell amid Translation weakness; FY2027 growth is forecast, with lower FY2028 targets.2483
Q4 2026